Authors
HER2-positive metastatic breast cancer patient.
MSN, RN, PMGT-BC.
Herigodt serves as the director of Partnerships and Engagement, a Cancer Support specialist, and director of Programs and Outreach at Imerman Angels.
Baker, a survivor and patient advocate based in the United Kingdom, received a diagnosis of essential thrombocythemia (ET) in 1991, followed by polycythemia vera (PV) in 2004.
Advertisement
Advertisement
